TTS Pharma is the first UK manufacturer to produce commercial cannabidiol free of illegal THC and CBN
LIVERPOOL AND LONDON, UK - Sep 19, 2019 - TTS Pharma Limited, a producer of the highest quality, legal and safe cannabinoids (including Cannabidiol (CBD)) for use in food, cosmetics and nutraceuticals, today announces the results of an independent analysis of its CBD oil. The analysis shows TTS Pharmas CBD oil is free from THC and CBN as well as harmful environmental contaminants. A simultaneous landscape analysis of CBD consumer products currently available in the UK, commissioned by TTS Pharma, revealed products contaminated with illegal levels of THC and CBN, harmful environmental impurities and inaccurate labelling of CBD content.
TTS Pharma engaged an independent analytical laboratory, Fera Science Ltd, to undertake a series of in-depth analytical tests to ensure that its product fully complies with all regulatory requirements. The analysis demonstrates that TTS Pharmas CBD oil is completely free of THC and CBN (within the limits of detection, <0.0001%) and confirms that the isolate is exempt from the Misuse of Drugs Regulations (UK Government 2001).